MedLife has launched Longevity 100+, the first and largest genetic testing program in Central and Eastern Europe, offering free advanced genetic testing for 4,000 people — employees of MedLife, BCR, World Class, and Decathlon. The initiative marks a significant step toward personalized and preventive medicine in Romania.
The program’s results will form the basis of the first large-scale study on the genetic characteristics of Romania’s active population, aiming to support the development of national preventive healthcare policies. The project is fully funded by MedLife Group.
From reactive to preventive medicine
Against a backdrop of rising chronic diseases, healthcare system strain, and advances in AI and genomics, Longevity 100+ represents a shift from reactive medicine — focused on treating illness — to preventive and personalized care.
Read full article here: turnovernews.com
Sursa foto: Economedia
UK
IT
ES
DE
FR
RO
PT
HU
